openPR Logo
Press release

Bio Engineered Protein Drugs Market Scenario Highlighting Major Drivers & Trends, 2017- 2025 , says PMR

Bio Engineered Protein Drugs Market Scenario Highlighting

The application of engineering methods and technology to the field of biology is called as bioengineering. Proteins are polymer of amino acids and play an important role in the function of body. Bioengineered proteins are synthesized using genetic engineering. They are also called as recombinant protein. Bioengineered protein drugs are used in treatment of human injury, treatment of cancers, hormonal disorders and chronic diseases such as diabetes, asthma, heart disease etc.

Bioengineered protein drugs are target specific and are highly efficient, they are said to have better PK and PD. The bioengineered protein drugs match the natural biological process and therefore they have lower side effects and higher acceptance as compared to small molecule drug. These are few of the key factors attributing the growth of the global bioengineered protein drug market. In addition to these, the time duration required for the FDA approval and clinical development process is comparatively less than small molecule drugs which is a significant factor driving the growth of the global bioengineered protein drug market. Huge development in biopharmaceuticals, technological advancement in drug delivery system are driving the growth of the global market. Furthermore, rise in prevalence of chronic disease such as diabetes, asthma and systemic diseases like cancer is likely to propel the growth of the global bioengineered protein drugs market. According to WHO, the worldwide diabetes population will grow to 366 million by 2030, influencing positively the rapid growth in global bioengineered protein drug market through 2024. However, the complication involved in treatment of disease using bioengineered protein drugs and the ever increasing cost of the drugs is likely to hamper the growth of global market during the forecast period.

The global bioengineered protein drugs market is segmented on the basis of product types, application types, technology types, drug delivery methods and geographical regions.

Based on product type, the global Bioengineered protein drug market is divided into following

Cytokines and Chemokines
Peptide Hormones
Peptide antibiotics
Monoclonal antibodies
Therapeutics and enzymes
Vaccines
Other Bioengineered protein drugs

Cytokines and Chemokines can be subdivided into Interleukins, Interferon and colony stimulating factors. Peptide hormones can be subdivided into growth hormone, erythropoietin, luteinizing hormone and Follicle Stimulating hormone. Vaccines can be subdivided into Toxoid, Inactivated vaccines, Attenuated Vaccines. Therapeutics and enzymes can be subdivided into metabolic enzymes, digestive enzymes and others. There is an increase in demand of monoclonal antibody due to its increased use in therapeutics for cancer, autoimmune diseases and cancer.

Request to Sample Report @ https://www.persistencemarketresearch.com/samples/3295

Based on Application type, the global bioengineered protein drug market is divided into following

Diabetes and hormonal disorders
Genetic and fertility disorders
Cancer and Immunosuppressive disorders
Other diseases

Based on technology type, the global bioengineered protein drug market is divided into following

Fractionation
Bioreactors and microbial cell fermentation
Genetic Engineering
Pharming
Cell culture and other

Based on drug delivery methods, the global bioengineered protein drug market is divided into following

Traditional methods
Novel Methods

The traditional methods are subdivided into oral, Trans mucosal, parenteral, topical and inhalation. The novel methods are subdivided into micelles, microspheres, liposomes, micro emulsions, nanoparticles, hydrogels, and thin-film drug delivery.

Request Report TOC @ https://www.persistencemarketresearch.com/toc/3295

Geographically the global bioengineered protein drug market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region is dominating the global bioengineered protein drug market share in terms of value and volume followed by Europe. North America is expected to lead the global market through 2024 due to improved biopharmaceutical industries, greater technological advancements and highly developed research sector etc. Asia Pacific sector is expected to register highest growth rate in the global bioengineered protein drug market owing to the factors such as developing economic scenario, improving biopharmaceutical industries, developing research sector, increase awareness of people towards technology and rise in prevalence of chronic diseases such as diabetes, asthma etc.

Some of the major players operating in the global bioengineered protein drug markets are Abbott Laboratories, Allergan, Pfizer Inc., Genentech, Inc., Lilly USA, LLC, GlaxoSmithKline plc, Panacea Biotec Ltd., Wockhardt Ltd., Allergan, Novo Nordisk, F. Hoffmann-La Roche Ltd., Amgen, Biogen, Bayer Healthcare Pharmaceuticals, Baxter Healthcare among others worldwide. To maintain a significant position in the global market, the players are adopting strategies such as providing highly efficient and cost effective bioengineered protein drugs, launches and mergers.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bio Engineered Protein Drugs Market Scenario Highlighting Major Drivers & Trends, 2017- 2025 , says PMR here

News-ID: 1595199 • Views:

More Releases from Persistence Market Research

Biological Safety Testing Market to Register High CAGR of 11.3% Through 2032
Biological Safety Testing Market to Register High CAGR of 11.3% Through 2032
The global biological safety testing market is poised for significant growth in the coming years, with market valuation expected to rise from USD 4.85 billion in 2025 to USD 10.26 billion by 2032, registering a robust compound annual growth rate (CAGR) of 11.3% during the forecast period. This growth trajectory is primarily fueled by the increasing demand for biopharmaceuticals, stringent regulatory requirements across the globe, and rapid advancements in biotechnology
Beverage Refrigeration Equipment Market Innovations, Efficiency, and Emerging Trends Shaping Cold Beverage Solutions
Beverage Refrigeration Equipment Market Innovations, Efficiency, and Emerging Tr …
The global beverage refrigeration equipment market is witnessing rapid growth as businesses and consumers increasingly demand efficient, reliable, and technologically advanced solutions for cooling beverages. Beverage refrigeration equipment, ranging from commercial coolers and display refrigerators to industrial-grade storage units, plays a pivotal role in maintaining product quality, freshness, and consumer satisfaction. The global beverage refrigeration equipment market size is likely to be valued at US$2.2 Bn in 2025 and is
U.S. CMO/CDMO Market Forecast Highlights Significant CAGR of 8.7% from 2025-2032
U.S. CMO/CDMO Market Forecast Highlights Significant CAGR of 8.7% from 2025-2032
The U.S. Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) market is poised for robust expansion, driven by growing demand across pharmaceutical and biopharmaceutical sectors. Valued at approximately US$83.1 billion in 2025, the market is projected to reach US$149.4 billion by 2032, registering a compound annual growth rate (CAGR) of 8.7% during the forecast period. This growth trajectory reflects increased outsourcing of key drug development and manufacturing
Weaving Machine Market Innovations, Automation, and Emerging Trends Transforming the Textile Industry
Weaving Machine Market Innovations, Automation, and Emerging Trends Transforming …
The global weaving machine market is experiencing remarkable growth, driven by technological advancements, automation, and the increasing demand for high-quality textiles across industries. Weaving machines, which are essential for producing fabrics ranging from everyday clothing to technical textiles, have evolved significantly from traditional handlooms to fully automated systems. Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/32132 The textile industry's focus on efficiency,

All 5 Releases


More Releases for Bioengineered

Evolving Market Trends In The Bioengineered Food Industry: Advancements In Insec …
The Bioengineered Food Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Bioengineered Food Market Size During the Forecast Period? The bioengineered food market has grown rapidly, projected to increase from $34.53 billion in 2024 to $38.32 billion in 2025 at a CAGR
Breakthroughs in Bioengineered Protein Therapeutics
The Business Research Company recently released a comprehensive report on the Global Bioengineered Protein Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The bioengineered protein drugs
Bioengineered Protein Drugs Market: Growth Trends 2023-2030
According to Triton Market Research's report, the global bioengineered protein drugs market is estimated to gather revenue at a CAGR of 7.7% during 2023-2030. A recent study by Triton Market Research titled Global Bioengineered Protein Drugs Market consists of the Global Analysis and Forecasts by Disease (Autoimmune Diseases and Other Immunodeficiency Disorders, Infectious Diseases, Solid Tumors, Diabetes, Blood Disorders, Growth Hormone Disorders, Enzyme Disorders, and Infertility, Other Diseases), Type (Monoclonal Antibodies,
Market Trends for Bioengineered Protein Drugs, 2023-2030
According to Triton Market Research's report, the global bioengineered protein drugs market is estimated to gather revenue at a CAGR of 7.7% during 2023-2030. A recent study by Triton Market Research titled Global Bioengineered Protein Drugs Market consists of the Global Analysis and Forecasts by Disease (Autoimmune Diseases and Other Immunodeficiency Disorders, Infectious Diseases, Solid Tumors, Diabetes, Blood Disorders, Growth Hormone Disorders, Enzyme Disorders, and Infertility, Other Diseases), Type (Monoclonal Antibodies,
Bioengineered Protein Drugs Market: Growth Trends 2023-2030
According to Triton Market Research's report, the global bioengineered protein drugs market is estimated to gather revenue at a CAGR of 7.7% during 2023-2030. A recent study by Triton Market Research titled Global Bioengineered Protein Drugs Market consists of the Global Analysis and Forecasts by Disease (Autoimmune Diseases and Other Immunodeficiency Disorders, Infectious Diseases, Solid Tumors, Diabetes, Blood Disorders, Growth Hormone Disorders, Enzyme Disorders, and Infertility, Other Diseases), Type (Monoclonal Antibodies,
Bioengineered Protein Drugs Market: Growth Trends 2023-2030
A recent study by Triton Market Research titled Global Bioengineered Protein Drugs Market consists of the Global Analysis and Forecasts by Disease (Autoimmune Diseases and Other Immunodeficiency Disorders, Infectious Diseases, Solid Tumors, Diabetes, Blood Disorders, Growth Hormone Disorders, Enzyme Disorders, and Infertility, Other Diseases), Type (Monoclonal Antibodies, Blood Factors and Peptide Antibiotics, Fusion Proteins, Vaccines (Excluding COVID-19), Therapeutic Enzymes, Peptide Hormones, Cytokines), and Regional Outlook (, Latin America, Asia-Pacific, North